| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 3.58B | 3.59B | 3.67B | 3.58B | 3.47B | 2.51B |
| Gross Profit | 1.54B | 1.03B | 507.60M | 570.36M | 1.60B | 1.17B |
| EBITDA | 436.00M | 424.35M | 275.83M | 403.59M | 480.30M | 276.09M |
| Net Income | 45.21M | 40.45M | 32.10M | 124.19M | 181.32M | 69.31M |
Balance Sheet | ||||||
| Total Assets | 0.00 | 4.74B | 4.81B | 3.97B | 3.33B | 2.63B |
| Cash, Cash Equivalents and Short-Term Investments | 114.02M | 112.27M | 503.78M | 613.15M | 576.12M | 324.58M |
| Total Debt | 0.00 | 2.63B | 2.81B | 1.99B | 1.28B | 973.63M |
| Total Liabilities | -1.37B | 3.37B | 3.47B | 2.65B | 2.12B | 1.58B |
| Stockholders Equity | 1.37B | 1.37B | 1.34B | 1.32B | 1.21B | 1.04B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -198.52M | -746.49M | -546.12M | 73.29M | 111.07M |
| Operating Cash Flow | 0.00 | -108.42M | 179.50M | -386.00K | 593.69M | 271.59M |
| Investing Cash Flow | 0.00 | 305.42M | -815.32M | -506.77M | -735.50M | -428.64M |
| Financing Cash Flow | 0.00 | -193.92M | 598.10M | 546.91M | 139.31M | 152.55M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
69 Neutral | ₹5.66B | 16.28 | ― | 0.63% | -5.18% | 18.80% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
57 Neutral | ₹1.19B | 26.30 | ― | 0.33% | -3.07% | 187.63% | |
57 Neutral | ₹9.98B | 15.57 | ― | ― | 67.43% | ― | |
55 Neutral | ₹3.20B | 29.62 | ― | ― | 25.88% | -44.00% | |
53 Neutral | ₹472.48M | -5.28 | ― | ― | -31.38% | -2648.39% | |
45 Neutral | ₹5.76B | -6.61 | ― | ― | -1.07% | -5.16% |
Reliance Chemotex Industries Ltd held its 47th Annual General Meeting on September 26, 2025, where shareholders approved several resolutions. These included the adoption of audited financial statements for the year ending March 31, 2025, the declaration of a final dividend, and the re-appointment of directors. Additionally, the meeting ratified the remuneration for cost auditors and appointed secretarial auditors, while also approving the re-appointment of Mr. Ameya Shroff as Executive Director for three years. These decisions are expected to ensure continued stability and governance within the company, potentially impacting its operational efficiency and stakeholder confidence.
Reliance Chemotex Industries Ltd has announced the closure of its trading window in compliance with SEBI’s insider trading regulations. This closure will be in effect from October 1, 2025, until 48 hours after the release of the company’s unaudited financial results for the quarter and half-year ending September 30, 2025. This move is part of the company’s regulatory compliance efforts and is intended to ensure transparency and fairness in trading activities.
Reliance Chemotex Industries Ltd. has announced that it has published newspaper advertisements in Financial Express and Jai Rajasthan, notifying stakeholders of the distribution of its Annual Report for the financial year 2024-25. The report, along with the notice for the 47th Annual General Meeting scheduled for September 26, 2025, was sent electronically to all company members, reflecting the company’s adherence to regulatory requirements and its commitment to transparency and stakeholder engagement.
Reliance Chemotex Industries Ltd has announced its 47th Annual General Meeting (AGM) scheduled for September 26, 2025, to be conducted via video conferencing. The company has also released its Annual Report for the financial year 2024-25 and recommended a final dividend of 5% for the year. The AGM and dividend payment details, including record dates and e-voting periods, have been outlined, indicating the company’s commitment to shareholder engagement and transparency.